(NP (NP (NN OBJECTIVE)) (: :) (S (VP (TO To) (VP (ADVP (JJR better)) (VB understand) (NP (NP (JJ clinician) (NNS needs) (CC and) (NNS preferences)) (PP (IN for) (NP (NP (DT the) (NN display)) (PP (IN of) (NP (JJ pharmacogenomic) (PRN (-LRB- -LRB-) (NNP PGx) (-RRB- -RRB-)) (NN information))) (PP (IN in) (NP (JJ clinical) (NN decision) (NN support) (PRN (-LRB- -LRB-) (NNP CDS) (-RRB- -RRB-)) (NNS tools))))))))) (. .))
(NP (NP (NNP MATERIALS) (CC AND) (NNP METHODS)) (: :) (S (NP (PRP We)) (VP (VBD developed) (NP (DT a) (JJ semi-structured) (NN interview)) (S (VP (TO to) (VP (VB collect) (NP (NP (NN feedback) (CC and) (NNS preferences)) (PP (IN in) (NP (NP (CD six) (JJ key) (NNS areas)) (PP (IN of) (NP (NNP PGx) (NNP CDS) (NN design)))))) (, ,) (PP (IN from) (NP (NP (NNS clinicians)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (NP (JJ prior) (NN experience)) (PP (IN with) (NP (JJ live) (NNP PGx) (NNP CDS) (NNS tools)))))))))))))) (. .))
(S (NP (NP (CD Eight) (NNS clinicians)) (PP (IN from) (NP (NP (NNP Northwestern) (NNP Medicine) (POS 's)) (PRN (-LRB- -LRB-) (NP (NNP NM)) (-RRB- -RRB-)) (NNP General) (NNP Internal) (NNP Medicine) (NN clinic)))) (VP (VBD participated) (PP (IN in) (NP (DT the) (NN study)))) (. .))
(NP (NP (NN RESULTS)) (: :) (S (NP (NNS Clinicians)) (VP (VBD expressed) (NP (NP (NN preference)) (PP (IN for) (NP (NP (NP (JJ interruptive) (JJ pop-up) (NNS alerts)) (PP (IN during) (NP (NN order) (NN entry)))) (, ,) (NP (NP (JJ brief) (NNS descriptions)) (PP (IN of) (NP (JJ relevant) (JJ drug-gene) (NNS interactions)))) (, ,) (CC and) (NP (NP (DT a) (ADJP (JJ clear) (CC and) (JJ specific)) (JJ recommended) (JJ alternative) (NN course)) (PP (IN of) (NP (NN action))) (SBAR (WHADVP (WRB when)) (S (NP (DT a) (NN medication)) (VP (VBZ is) (VP (VBN contraindicated))))))))))) (. .))
(S (NP (PRP They)) (VP (VBD did) (RB not) (VP (VB wish) (S (VP (TO to) (VP (VB see) (NP (JJ detailed) (JJ genetic) (NNS data))))) (, ,) (S (VP (VBG preferring) (NP (NP (NN phenotypic) (NN information)) (VP (VBD predicted) (PP (IN from) (NP (DT the) (NN genotype))))))))) (. .))
(SINV (CC Nor) (VBD did) (NP (PRP they)) (VP (VB wish) (S (VP (TO to) (VP (VB be) (VP (VBN interrupted) (SBAR (WHADVP (WRB when)) (S (NP (JJ genetic) (NN test) (NNS results)) (VP (VBP do) (RB not) (VP (VB indicate) (NP (NP (DT a) (NN change)) (PP (IN in) (NP (NN treatment) (NN plan))))))))))))) (. .))
(S (NP (NNS Clinicians)) (VP (VP (VBD reported) (NP (NP (JJ little) (NN familiarity)) (PP (IN with) (NP (NNP Clinical) (NNP Pharmacogenetic) (NNP Implementation) (NNP Consortium) (VBG prescribing) (NNS recommendations))))) (CC but) (VP (VBD reported) (S (VP (JJ trusting) (NP (NP (NNS recommendations)) (PP (IN of) (NP (NP (PRP$ their) (JJ professional) (NNS societies)) (CC and) (NP (NP (NNS resources)) (PP (IN like) (NP (NNP UpToDate))))))))))) (. .))
(S (NP (NP (NN Analysis)) (PP (IN of) (NP (JJ unstructured) (NNS comments)))) (VP (VBN concurred) (PP (IN with) (NP (JJ structured) (NNS results))) (, ,) (S (VP (VBG indicating) (NP (NP (DT a) (JJ general) (NN uncertainty)) (PP (IN among) (NP (NNS participants))) (PP (IN around) (SBAR (WHADVP (WRB how)) (S (VP (TO to) (VP (VB interpret) (CC and) (VB apply) (NP (NNP PGx) (NN information)) (PP (IN in) (NP (NN practice)))))))))))) (. .))
(NP (NP (NN DISCUSSION)) (: :) (S (NP (NNS Results)) (VP (VBP point) (PP (TO to) (NP (NP (NP (JJ several) (JJ underlying) (NNS principles)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB inform) (NP (JJ future) (NNP PGx) (NNP CDS) (JJ alert) (NNS designs))))))) (: :) (S (VP (NNP Be) (ADJP (NNP Specific) (CC and) (NNP Actionable))) (: ;) (VP (NNP Be) (ADJP (NNP Brief))) (: ;) (S (VP (NNP Display) (NP (NP (NNP Phenotypes)) (RB not) (NP (NNP Genotypes))))) (: ;) (S (VP (NNP Rely) (PP (IN on) (NP (NP (NNPS Sources)) (SBAR (S (NP (NNP Clinicians)) (ADVP (NNP Already)) (VP (NNP Trust)))))))) (: ;) (CC and) (, ,) (VP (NNP Be) (ADJP (NNP Adaptable) (PP (TO to) (NP (NNP Learning) (NNPS Effects)))))))))) (. .))
(NP (NP (NN CONCLUSION)) (: :) (S (NP (DT This) (NN study)) (VP (VP (VBZ is) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT a) (JJR broader) (JJ socio-technical) (NN design) (NN approach)) (PP (TO to) (NP (NNP PGx) (NNP CDS) (NN design))) (VP (RB underway) (PP (IN at) (NP (NNP NM)))))))) (CC and) (VP (VBZ provides) (NP (NP (DT a) (NN baseline)) (PP (IN for) (NP (JJ future) (NNP PGx) (NNP CDS) (NN development))))))) (. .))
(S (NP (NP (NNS Designs)) (PP (VBN based) (PP (IN on) (NP (DT these) (NNS results))))) (VP (VBP have) (NP (DT the) (NN potential) (S (VP (VP (TO to) (VP (VB improve) (NP (JJ clinician) (NN education) (CC and) (NN adherence) (NNS levels)))) (, ,) (CC and) (VP (TO to) (VP (VB improve) (NP (NN patient) (NNS outcomes)))))))) (. .))
